Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.160 | 8 | 128180025 | intron variant | T/C | snv | 0.27 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 3 | 2010 | 2014 | |||||||
|
0.925 | 0.080 | 8 | 127802783 | intron variant | T/C | snv | 0.74 |
|
Immune System Diseases; Nervous System Diseases | 0.800 | 1.000 | 2 | 2011 | 2013 | |||||||
|
0.925 | 0.160 | 8 | 128180025 | intron variant | T/C | snv | 0.27 |
|
Immune System Diseases; Nervous System Diseases | 0.800 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.120 | 8 | 128063586 | intron variant | T/C | snv | 0.50 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 1 | 2010 | 2010 | |||||||
|
1.000 | 0.120 | 8 | 127877125 | intron variant | A/C | snv | 0.53 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.800 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.080 | 8 | 128182395 | intron variant | C/T | snv | 0.13 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.710 | 1.000 | 3 | 2013 | 2017 | |||||||
|
8 | 128000328 | intron variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||||
|
8 | 128000328 | intron variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||||
|
8 | 127990173 | non coding transcript exon variant | G/A | snv | 0.31 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.040 | 8 | 128150251 | intron variant | A/C;G | snv |
|
Endocrine System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
8 | 127992729 | intron variant | G/A | snv | 0.31 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
8 | 127992729 | intron variant | G/A | snv | 0.31 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
1.000 | 0.080 | 8 | 128178298 | intron variant | C/A | snv | 0.24 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
8 | 127916000 | intron variant | C/T | snv | 0.27 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
8 | 127946525 | intron variant | C/T | snv | 0.24 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
8 | 127946525 | intron variant | C/T | snv | 0.24 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
8 | 128151049 | intron variant | A/C | snv | 0.24 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.882 | 0.120 | 8 | 128064205 | intron variant | C/T | snv | 0.24 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.120 | 8 | 128064205 | intron variant | C/T | snv | 0.24 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.120 | 8 | 128064327 | intron variant | C/T | snv | 0.24 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.080 | 8 | 128166844 | intron variant | A/C | snv | 0.26 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
8 | 128167680 | intron variant | A/G | snv | 0.26 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.040 | 8 | 128157880 | intron variant | C/G | snv | 0.37 |
|
Pathological Conditions, Signs and Symptoms | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 8 | 128157880 | intron variant | C/G | snv | 0.37 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.160 | 8 | 128102971 | intron variant | A/G | snv | 0.33 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 |